Published on 21 Jan 2024 on Simply Wall St. via Yahoo Finance
With 33% ownership, Nautilus Biotechnology, Inc. (NASDAQ:NAUT) insiders have a lot at stake
Key Insights
Nautilus Biotechnology's significant insider ownership suggests inherent interests in company's expansion51% of the business is held by the top 5 shareholders Institutions own 22% of Nautilus Biotechnology
A look at the shareholders of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) can tell us which group is most powerful. With 33% stake, individual insiders possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).